nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0246	0.031	CcSEcCtD
Buspirone—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0297	CcSEcCtD
Buspirone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0227	0.0287	CcSEcCtD
Buspirone—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.022	0.0277	CcSEcCtD
Buspirone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0262	CcSEcCtD
Buspirone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0233	CcSEcCtD
Buspirone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0205	CcSEcCtD
Buspirone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0199	CcSEcCtD
Buspirone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0185	CcSEcCtD
Buspirone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0184	CcSEcCtD
Buspirone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0143	0.018	CcSEcCtD
Buspirone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.014	0.0177	CcSEcCtD
Buspirone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0176	CcSEcCtD
Buspirone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0171	CcSEcCtD
Buspirone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0168	CcSEcCtD
Buspirone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.013	0.0165	CcSEcCtD
Buspirone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0151	CcSEcCtD
Buspirone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0149	CcSEcCtD
Buspirone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0149	CcSEcCtD
Buspirone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0147	CcSEcCtD
Buspirone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0142	CcSEcCtD
Buspirone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0141	CcSEcCtD
Buspirone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0111	0.014	CcSEcCtD
Buspirone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0138	CcSEcCtD
Buspirone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0136	CcSEcCtD
Buspirone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0132	CcSEcCtD
Buspirone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0129	CcSEcCtD
Buspirone—HTR2A—urine—nephrolithiasis	0.00961	0.119	CbGeAlD
Buspirone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00953	0.012	CcSEcCtD
Buspirone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00949	0.012	CcSEcCtD
Buspirone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00904	0.0114	CcSEcCtD
Buspirone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0089	0.0112	CcSEcCtD
Buspirone—CYP3A4—urine—nephrolithiasis	0.0089	0.11	CbGeAlD
Buspirone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00877	0.0111	CcSEcCtD
Buspirone—CYP2D6—urine—nephrolithiasis	0.00875	0.109	CbGeAlD
Buspirone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00874	0.011	CcSEcCtD
Buspirone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00872	0.011	CcSEcCtD
Buspirone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00865	0.0109	CcSEcCtD
Buspirone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00856	0.0108	CcSEcCtD
Buspirone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00839	0.0106	CcSEcCtD
Buspirone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00834	0.0105	CcSEcCtD
Buspirone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00826	0.0104	CcSEcCtD
Buspirone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0103	CcSEcCtD
Buspirone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00813	0.0103	CcSEcCtD
Buspirone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00803	0.0101	CcSEcCtD
Buspirone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.008	0.0101	CcSEcCtD
Buspirone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00798	0.0101	CcSEcCtD
Buspirone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00797	0.0101	CcSEcCtD
Buspirone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00787	0.00994	CcSEcCtD
Buspirone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00989	CcSEcCtD
Buspirone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00771	0.0957	CbGeAlD
Buspirone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00958	CcSEcCtD
Buspirone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00958	CcSEcCtD
Buspirone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00958	CcSEcCtD
Buspirone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00946	CcSEcCtD
Buspirone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00937	CcSEcCtD
Buspirone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00733	0.00926	CcSEcCtD
Buspirone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00918	CcSEcCtD
Buspirone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00903	CcSEcCtD
Buspirone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00711	0.00899	CcSEcCtD
Buspirone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00709	0.00896	CcSEcCtD
Buspirone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00888	CcSEcCtD
Buspirone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00875	CcSEcCtD
Buspirone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00679	0.00858	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00836	CcSEcCtD
Buspirone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.0066	0.0819	CbGeAlD
Buspirone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00657	0.0083	CcSEcCtD
Buspirone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00824	CcSEcCtD
Buspirone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00648	0.00819	CcSEcCtD
Buspirone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00816	CcSEcCtD
Buspirone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00808	CcSEcCtD
Buspirone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00798	CcSEcCtD
Buspirone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00792	CcSEcCtD
Buspirone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00785	CcSEcCtD
Buspirone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00785	CcSEcCtD
Buspirone—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00603	0.0471	CbGpPWpGaD
Buspirone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00757	CcSEcCtD
Buspirone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00729	CcSEcCtD
Buspirone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00726	CcSEcCtD
Buspirone—DRD3—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00561	0.0438	CbGpPWpGaD
Buspirone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00676	CcSEcCtD
Buspirone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00659	CcSEcCtD
Buspirone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00514	0.0065	CcSEcCtD
Buspirone—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00507	0.0396	CbGpPWpGaD
Buspirone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00628	CcSEcCtD
Buspirone—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00489	0.0382	CbGpPWpGaD
Buspirone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00607	CcSEcCtD
Buspirone—DRD3—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00472	0.0368	CbGpPWpGaD
Buspirone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00584	CcSEcCtD
Buspirone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00579	CcSEcCtD
Buspirone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00578	CcSEcCtD
Buspirone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00575	CcSEcCtD
Buspirone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00545	CcSEcCtD
Buspirone—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00429	0.0335	CbGpPWpGaD
Buspirone—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00423	0.033	CbGpPWpGaD
Buspirone—HTR2B—cortex of kidney—nephrolithiasis	0.00415	0.0515	CbGeAlD
Buspirone—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00411	0.0321	CbGpPWpGaD
Buspirone—HTR1A—renal system—nephrolithiasis	0.00395	0.049	CbGeAlD
Buspirone—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00361	0.0282	CbGpPWpGaD
Buspirone—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00355	0.0277	CbGpPWpGaD
Buspirone—CYP3A5—nephron tubule—nephrolithiasis	0.00319	0.0396	CbGeAlD
Buspirone—CYP3A5—renal system—nephrolithiasis	0.0029	0.036	CbGeAlD
Buspirone—CYP3A5—kidney—nephrolithiasis	0.0028	0.0348	CbGeAlD
Buspirone—CYP3A5—cortex of kidney—nephrolithiasis	0.00273	0.0339	CbGeAlD
Buspirone—DRD3—GPCRs, Other—CHRM3—nephrolithiasis	0.00249	0.0195	CbGpPWpGaD
Buspirone—DRD3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00239	0.0187	CbGpPWpGaD
Buspirone—HTR2A—renal system—nephrolithiasis	0.00235	0.0292	CbGeAlD
Buspirone—HTR2A—kidney—nephrolithiasis	0.00227	0.0282	CbGeAlD
Buspirone—CYP3A4—renal system—nephrolithiasis	0.00218	0.027	CbGeAlD
Buspirone—CYP2D6—renal system—nephrolithiasis	0.00214	0.0266	CbGeAlD
Buspirone—CYP3A4—kidney—nephrolithiasis	0.0021	0.0261	CbGeAlD
Buspirone—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00208	0.0163	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00208	0.0163	CbGpPWpGaD
Buspirone—CYP2D6—kidney—nephrolithiasis	0.00207	0.0257	CbGeAlD
Buspirone—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00202	0.0158	CbGpPWpGaD
Buspirone—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00188	0.0147	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00186	0.0145	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00183	0.0143	CbGpPWpGaD
Buspirone—ABCB1—nephron tubule—nephrolithiasis	0.00169	0.021	CbGeAlD
Buspirone—ABCB1—renal system—nephrolithiasis	0.00154	0.0191	CbGeAlD
Buspirone—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00151	0.0118	CbGpPWpGaD
Buspirone—ABCB1—kidney—nephrolithiasis	0.00149	0.0185	CbGeAlD
Buspirone—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00146	0.0114	CbGpPWpGaD
Buspirone—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00146	0.0114	CbGpPWpGaD
Buspirone—ABCB1—cortex of kidney—nephrolithiasis	0.00145	0.018	CbGeAlD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00135	0.0105	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00131	0.0102	CbGpPWpGaD
Buspirone—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00116	0.00909	CbGpPWpGaD
Buspirone—DRD3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00108	0.00846	CbGpPWpGaD
Buspirone—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00105	0.00824	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00104	0.0081	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000997	0.00779	CbGpPWpGaD
Buspirone—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000944	0.00737	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000944	0.00737	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000928	0.00725	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000879	0.00686	CbGpPWpGaD
Buspirone—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000829	0.00647	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000818	0.00638	CbGpPWpGaD
Buspirone—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000815	0.00637	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000809	0.00631	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000798	0.00623	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000759	0.00593	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—RGS14—nephrolithiasis	0.000743	0.0058	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000713	0.00556	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00071	0.00554	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—CHRM3—nephrolithiasis	0.000707	0.00552	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0007	0.00547	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0007	0.00547	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000699	0.00545	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.000695	0.00542	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000678	0.0053	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000647	0.00505	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—PTH—nephrolithiasis	0.000646	0.00505	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000626	0.00489	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000624	0.00487	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000616	0.00481	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000616	0.00481	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000594	0.00463	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000571	0.00446	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000571	0.00446	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000568	0.00444	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000563	0.0044	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000559	0.00437	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000554	0.00433	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000552	0.00431	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000541	0.00422	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000539	0.00421	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000532	0.00415	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	0.000516	0.00403	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	0.000502	0.00392	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000495	0.00386	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000487	0.0038	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000481	0.00376	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.000471	0.00368	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000456	0.00356	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00045	0.00351	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.000439	0.00342	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000437	0.00341	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000432	0.00338	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000432	0.00338	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000429	0.00335	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000423	0.0033	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000416	0.00325	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000406	0.00317	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000402	0.00314	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000402	0.00314	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000399	0.00312	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000395	0.00308	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000393	0.00306	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00039	0.00304	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000388	0.00303	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000384	0.003	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000382	0.00298	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000378	0.00295	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.000365	0.00285	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000363	0.00283	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000358	0.0028	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000358	0.0028	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.000356	0.00278	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000348	0.00272	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000345	0.0027	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000345	0.0027	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000336	0.00262	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.000332	0.00259	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.00033	0.00258	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000329	0.00257	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000318	0.00249	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.000318	0.00249	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000318	0.00249	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000316	0.00247	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000306	0.00239	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000301	0.00235	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.000296	0.00231	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000296	0.00231	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000293	0.00229	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000289	0.00226	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000286	0.00224	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000279	0.00218	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000277	0.00217	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000275	0.00215	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000273	0.00213	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000258	0.00202	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000258	0.00202	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000254	0.00198	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.00025	0.00195	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APRT—nephrolithiasis	0.00025	0.00195	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.00025	0.00195	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000248	0.00194	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000246	0.00192	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000234	0.00183	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.00023	0.0018	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000227	0.00177	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000227	0.00177	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000223	0.00174	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000223	0.00174	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000222	0.00174	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000221	0.00173	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.000214	0.00167	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.000211	0.00164	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000209	0.00163	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000196	0.00153	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APRT—nephrolithiasis	0.000188	0.00147	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000188	0.00147	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000187	0.00146	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000178	0.00139	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000177	0.00139	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000177	0.00139	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000171	0.00133	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000164	0.00128	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000161	0.00126	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000161	0.00126	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000153	0.0012	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.00015	0.00117	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000148	0.00115	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000136	0.00107	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000134	0.00105	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000126	0.000987	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000121	0.000947	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000116	0.000906	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000116	0.000906	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000114	0.000893	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000106	0.000825	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SPP1—nephrolithiasis	9.84e-05	0.000768	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	8.57e-05	0.000669	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.27e-05	0.000645	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SPP1—nephrolithiasis	7.53e-05	0.000588	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.48e-05	0.000584	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	7.41e-05	0.000578	CbGpPWpGaD
